February 01, 2015 9:48 PM ET


Company Overview of FASgen, Inc.

Company Overview

FASgen, Inc. develops and commercializes small molecule therapeutics and diagnostics using fatty acid biosynthesis targets. The company focuses on creating treatments for cancer, tuberculosis, infectious diseases, and other serious widespread diseases; and metabolic disorders, such as obesity and diabetes. Its product portfolio includes FAS-detect IHC, a monoclonal antibody specific for fatty acid synthase (FAS); and FAS-detect ELISA, a quantitative enzyme-linked immunosorbent assay for the detection of FAS in human serum. The company was founded in 1999 and is based in Baltimore, Maryland.

Bayview Medical Campus

Alpha Center, 2nd Floor

5210 Eastern Avenue

Baltimore, MD 21224

United States

Founded in 1999





Key Executives for FASgen, Inc.

Chief Executive Officer
Co-Founder and Chairman
Founder and Director
Co-Founder and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Soluble Products Co., L.P. United States
RiboNovix, Inc. United States
Q-Pharma LLC United States
Island Pharmacy Services, Inc. United States
Verne Mendel Medical Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FASgen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.